STAAR Surgical | STAA - Equity Capital And Reserves


STAAR Surgical reported $344.18M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Bausch Health Companies USD -554M 910M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Cerus USD 61.46M 6.04M Sep/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Exact Sciences USD 2.4B 100.37M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
J&J USD 78.47B 0 Sep/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
Novartis USD 44.75B 2.7B Sep/2025
OraSure Technologies USD 340.83M 21.15M Dec/2025
Orthofix International USD 450.04M 7.55M Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Utah Medical Products USD 118.25M 719K Sep/2025